Saturday, July 13, 2024
spot_img
HomeBusinessGLAXO SMITH (GSK) INTENDS TO CHALLENGE DRUG COURT RULING ON SUB-STANDARD MEDICINES

GLAXO SMITH (GSK) INTENDS TO CHALLENGE DRUG COURT RULING ON SUB-STANDARD MEDICINES

Glaxo Smith Kline Pakistan Limited (“GSK”) ne Drug Court ke fesley ko challange karne ka irada kar liya.

Drug Court Rawalpindi ne April 22, 2024 ko ek fesla sunaya hai, jis mein GSK ke officers ke khilaf sub-standard medicines ki farahmi karne ka ilzam shamil hai. 

GSK aur officers ne is mamlay mein kisi bhi qisam ki involvment se inkaar kiya he aur bataya he ke wo appellate forum ke saamne upar zikar shuda faislay ko challenge karne ke liye foran qadam utha rahe hain.

- Advertisment -spot_imgspot_imgspot_imgspot_img

Most Popular

×